Otsuka Holdings Co., Ltd. (OTSKY)
| Market Cap | 31.80B |
| Revenue (ttm) | 16.34B |
| Net Income (ttm) | 3.03B |
| Shares Out | n/a |
| EPS (ttm) | 5.70 |
| PE Ratio | 10.48 |
| Forward PE | n/a |
| Dividend | 0.93 (3.34%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 5,776 |
| Average Volume | 42,739 |
| Open | 28.88 |
| Previous Close | 28.63 |
| Day's Range | 28.88 - 29.09 |
| 52-Week Range | 21.64 - 31.73 |
| Beta | -0.13 |
| RSI | 61.90 |
| Earnings Date | Feb 13, 2026 |
About Otsuka Holdings
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipme... [Read more]
Financial Performance
In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.
Financial numbers in JPY Financial StatementsNews
US FDA approves Otsuka's kidney disease drug
The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's website showed on Tuesday.
Otsuka Pharma Submits NDA For Centanafadine In ADHD
(RTTNews) - Japan-based Otsuka Pharmaceutical Co., Ltd., a wholly owned subsidiary of Otsuka Holdings Co., Ltd. (4578.T, OTSKF), has submitted a New Drug Application to the FDA for Centanafadine, its ...
Otsuka 9-month Profit Rises; Revenue Up 5.1%
(RTTNews) - Otsuka Holdings Co. (4578.T) reported that its nine month profit attributable to owners of the company was 297.7 billion yen, an increase of 55.3% from last year. Earnings per share was 56...
Taiho Pharma, Haihe Biopharma Enter Into Agreement For Ovarian Cancer Drug Candidate Risovalisib
(RTTNews) - Taiho Pharma, a subsidiary of Otsuka Holdings Co., Ltd. (4578.T,OTSKF) and Haihe Biopharma Co., Ltd., a Chinese biopharmaceutical company, announced on Thursday that they have entered into...
Shares of Asian drugmakers drop after Trump threatens tariffs
Shares of Asian drugmakers mostly fell on Friday after U.S. President Donald Trump threatened 100% tariffs on imports of branded pharmaceuticals from October 1, unless their producers had already brok...
Otsuka Corporation (OSUKF) Q1 FY2025 Earnings Call Transcript
Otsuka Corporation (OTCPK:OSUKF) Q1 FY2025 Earnings Conference Call August 1, 2025 2:30 AM ET Company Participants Yuji Otsuka - CEO, President, Chairman & MM Division Chief Yuji Otsuka I am Otsuka of...
Otsuka Holdings Co., Ltd. (OTSKY) Q2 FY2024 Earnings Call Transcript
Full Year 2024 Otsuka Holdings Co Ltd Earnings Presentation Transcript
Full Year 2024 Otsuka Holdings Co Ltd Earnings Presentation Transcript
Otsuka Holdings reports FY results
Otsuka Holdings Co., Ltd. reports Q3 results
Otsuka Holdings Co., Ltd. reported a significant increase in revenue and profit for the nine-month period ended September 30.
Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific
Otsuka Holdings Co. is considering options for its holding in Hong Kong-listed MicroPort Scientific Corp., including selling its stake in the medical device maker, according to people familiar with th...